Lung - Cancer
This murine model study investigated a novel combination treatment for pleural mesothelioma using intracavitary cisplatin-fibrin gel (cis-fib) and adjuvant irradiation (IR). Conducted on an orthotopic immunocompetent rat model, the study demonstrates that the combination therapy...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Timur Kyashif, a cardiac resident at Jena University Hospital in Jena, Germany, about the German Society for Thoracic, Cardiac,...
In this noteworthy interview, CTSNet Editor-in-Chief Joel Dunning speaks with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San Francisco,...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Jeffrey Velotta, Assistant Clinical Professor of Surgery at the University of California, San Francisco School of Medicine in San...
This Society of Thoracic Surgeons Expert Consensus Documents provides updated, multidisciplinary guidance on the multimodal management of pleural mesothelioma (PM). The expert panel emphasizes that surgical resection should only be...
Anatomical sublobar resections, both segmental and subsegmental, are becoming more and more common. They are used to treat benign lesions and pulmonary metastasis, but they are especially used because they...
Background A 31-year-old woman who was a former ice hockey player, was in the military, and is a lifetime never-smoker presented with a medical history of asthma, migraine headaches, endometriosis,...
Patient Care and General Interest A charity bazaar raised money for a Shanghai Chest Hospital project that offers free heart surgery to children with congenital heart disease in China. Trillium...
This randomized trial evaluating the relative efficacy of immunotherapy and chemotherapy in patients with recurrent or metastatic disease, immunotherapy was associated with significantly better progression-free survival. Tumor mutational burden was...
The addition of pembrolizumab (targeting PD-1) to standard chemotherapy substantially improved time to progression and overall survival compared to chemotherapy alone in patients with metastatic lung cancer.
...Find it here: The 26th ESTS Meeting in Ljubljana, Slovenia. Don’t miss the 2018 Meeting of the European Society of Thoracic Surgeons! Educational sessions from the meeting can also be...
The age-specific incidence of non-small cell lung cancer has reversed in individuals born since the 1960s, with women now having a higher incidence than men. This trend is not explained...
This is among the first and largest summaries of the use of neoadjuvant PD-1 inhibitor (nivolumab) in patients with resectable lung cancer. The safety profile was adequate, 20 of 21...




